HOTARARE   Nr. 516 din  8 mai 2003

privind modificarea si completarea Hotararii Guvernului nr. 1.417/2002 pentru aprobarea Listei cuprinzand medicamentele de care beneficiaza asiguratii in tratamentul ambulatoriu, cu sau fara contributie personala, pe baza de prescriptie medicala, in sistemul de asigurari sociale de sanatate

ACT EMIS DE: GUVERNUL ROMANIEI

ACT PUBLICAT IN: MONITORUL OFICIAL  NR. 321 din 13 mai 2003

    In temeiul art. 107 din Constitutie,

    Guvernul Romaniei adopta prezenta hotarare.

    ARTICOL UNIC
    Anexele nr. 1 si 2 la Hotararea Guvernului nr. 1.417/2002 pentru aprobarea Listei cuprinzand medicamentele de care beneficiaza asiguratii in tratamentul ambulatoriu, cu sau fara contributie personala, pe baza de prescriptie medicala, in sistemul de asigurari sociale de sanatate, publicata in Monitorul Oficial al Romaniei, Partea I, nr. 927 din 18 decembrie 2002, se inlocuiesc cu anexele nr. 1 si 2*) care fac parte integranta din prezenta hotarare.
------------
    *) Anexele nr. 1 si 2 sunt reproduse in facsimil.

                  PRIM-MINISTRU
                  ADRIAN NASTASE

                         Contrasemneaza:
                         Ministrul sanatatii si familiei,
                         Daniela Bartos

                         Presedintele Casei Nationale
                         de Asigurari de Sanatate,
                         Eugeniu Turlea

    ANEXA 1

    LISTA DENUMIRILOR COMUNE INTERNATIONALE ALE PRODUSELOR MEDICAMENTOASE DE CARE BENEFICIAZA ASIGURATII, IN AMBULATORIU FARA CONTRIBUTIE PERSONALA

    Sectiunea A - Medicamente de baza, optiune terapeutica 1

    1. INSUFICIENTA CARDIACA CRONICA
 ______________________________________________________________________________
|Nr. |Nr. |  Grupa   |                          D.C.I.                         |
|crt.|crt.|  ATC     |                                                         |
|____|____|__________|_________________________________________________________|
|  1.|  1.| C01A A05 | Digoxinum                                               |
|____|____|__________|_________________________________________________________|
|  2.|  2.| C03A A03 | Hydrochlorothiazidum                                    |
|____|____|__________|_________________________________________________________|
|  3.|  3.| C09A A01 | Captoprilum                                             |
|____|____|__________|_________________________________________________________|
|  4.|  4.| C09A A02 | Enalaprilum                                             |
|____|____|__________|_________________________________________________________|
|  5.|  5.| C03C A01 | Furosemidum                                             |
|____|____|__________|_________________________________________________________|
|  6.|  6.| C03D A01 | Spironolactonum                                         |
|____|____|__________|_________________________________________________________|

    2. BOLNAVI CU PROTEZE VALVULARE SI VASCULARE
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
|  7.|  1.| B01A A07 | Acenocoumarolum                                         |
|____|____|__________|_________________________________________________________|
|  8.|  2.| B01A C06 | Acidum acetylsalicylicum cp. cu concentratie pana la    |
|    |    |          | 100 mg                                                  |
|____|____|__________|_________________________________________________________|

    3. ACCIDENT VASCULAR CEREBRAL POSTACUT (inclusiv atacul vascular cerebral tranzitoriu)
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
|  9.|  1.| B01A A07 | Acenocoumarolum                                         |
|____|____|__________|_________________________________________________________|
| 10.|  2.| B01A C06 | Acidum acetylsalicylicum cp. cu concentratie pana la    |
|    |    |          | 100 mg                                                  |
|____|____|__________|_________________________________________________________|

    4. HEPATITA VIRALA ACUTA (cu HAV, HBV, HCV sau HGV), hepatitele cronice de etiologie virala (cu markeri de replicare virala pozitivi).

    5. CIROZA HEPATICA
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 11.|  1.| A05A A02 | Acidum ursodeoxycholicum                                |
|____|____|__________|_________________________________________________________|
| 12.|  2.| A06A D11 | Lactulosum                                              |
|____|____|__________|_________________________________________________________|
| 13.|  3.| C03C A01 | Furosemidum                                             |
|____|____|__________|_________________________________________________________|
| 14.|  4.| C03D A01 | Spironolactonum                                         |
|____|____|__________|_________________________________________________________|
| 15.|  5.| C07A A05 | Propranololum                                           |
|____|____|__________|_________________________________________________________|
| 16.|  6.| H02A B07 | Prednisonum                                             |
|____|____|__________|_________________________________________________________|
| 17.|  7.| J01C A01 | Ampicillinum                                            |
|____|____|__________|_________________________________________________________|
| 18.|  8.| J01M A06 | Norfloxacinum                                           |
|____|____|__________|_________________________________________________________|
| 19.|  9.| J05A F05 | Lamivudinum                                             |
|____|____|__________|_________________________________________________________|
| 20.|  9.| L04A X01 | Azatioprinum                                            |
|____|____|__________|_________________________________________________________|
| 21.| 10.| V03A C01 | Deferoxaminum                                           |
|____|____|__________|_________________________________________________________|

    6. HIV/SIDA
    Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor sanitare, prin care se deruleaza Programul National HIV/SIDA.

    7. TALASEMIE
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 22.|  1.| V03A C01 | Deferoxaminum                                           |
|____|____|__________|_________________________________________________________|

    8. LEUCEMII, LIMFOAME SI APLAZIE MEDULARA TUMORI MALIGNE
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 23.|  1.| A03F A01 | Metoclopramidum                                         |
|____|____|__________|_________________________________________________________|
| 24.|  2.| A04A A01 | Ondansetronum                                           |
|____|____|__________|_________________________________________________________|
| 25.|  3.| H02A B02 | Dexamethasonum                                          |
|____|____|__________|_________________________________________________________|
| 26.|  4.| N02A A01 | Morphinum                                               |
|____|____|__________|_________________________________________________________|
| 27.|  5.| N02A A08 | Dihydrocodeinum                                         |
|____|____|__________|_________________________________________________________|
| 28.|  6.| N02A B02 | Pethidinum                                              |
|____|____|__________|_________________________________________________________|
| 29.|  7.| N02A X02 | Tramadolum                                              |
|____|____|__________|_________________________________________________________|
| 30.|  8.| N02A A03 | Hydromorphonum                                          |
|____|____|__________|_________________________________________________________|
| 31.|  9.| N05A N01 | Lithii carbonas                                         |
|____|____|__________|_________________________________________________________|
| 32.| 10.| N07B C02 | Methadonum                                              |
|____|____|__________|_________________________________________________________|
| 33.| 11.| R05D A04 | Codeinum                                                |
|____|____|__________|_________________________________________________________|

    NOTA:
    Medicamentele (D.C.I.) aferente grupei "Leucemii, limfoame si aplazie medulara" sunt listate impreuna cu cele corespunzatoare grupei "Tumori maligne" datorita faptului ca un numar mare de produse sunt comune celor doua grupe.
    Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor sanitare, prin care se deruleaza Programul National de Cancer.

    9. EPILEPSIE
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 34.|  1.| N03A A02 | Phenobarbitalum                                         |
|____|____|__________|_________________________________________________________|
| 35.|  2.| N03A B02 | Phenitoinum                                             |
|____|____|__________|_________________________________________________________|
| 36.|  3.| N03A D01 | Ethosuximidum                                           |
|____|____|__________|_________________________________________________________|
| 37.|  4.| N03A E01 | Clonazepamum                                            |
|____|____|__________|_________________________________________________________|
| 38.|  5.| N03A F01 | Carbamazepinum                                          |
|____|____|__________|_________________________________________________________|
| 39.|  6.| N03A G01 | Acidum valproicum si saruri                             |
|____|____|__________|_________________________________________________________|
| 40.|  7.| N03A X09 | Lamotriginum                                            |
|____|____|__________|_________________________________________________________|
| 41.|  8.| N03A X11 | Topiramatum                                             |
|____|____|__________|_________________________________________________________|

    10. BOALA PARKINSON
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 42.|  1.| N04A A01 | Trihexyphenidilum                                       |
|____|____|__________|_________________________________________________________|
| 43.|  2.| N04A A02 | Biperidenum                                             |
|____|____|__________|_________________________________________________________|
| 44.|  3.| N04B A02 | Levodopum + Carbidopum                                  |
|____|____|__________|_________________________________________________________|
| 45.|  4.| N04B A02 | Levodopum + Benserazidum                                |
|____|____|__________|_________________________________________________________|
| 46.|  5.| N04B C04 | Ropinirolum*)                                           |
|____|____|__________|_________________________________________________________|
| 47.|  6.| N04B C05 | Pramipexolum*)                                          |
|____|____|__________|_________________________________________________________|
| 48.|  7.| N04B D01 | Selegilinum                                             |
|____|____|__________|_________________________________________________________|
    *) Numai cu avizul comisiilor din institutele de specialitate sau din centrele universitare.

    11. MIOPATII (MIOPATIILE INFLAMATORII)
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 49.|  1.| H02A B07 | Prednisonum                                             |
|____|____|__________|_________________________________________________________|
| 50.|  2.| L01A A01 | Cyclophosphamidum                                       |
|____|____|__________|_________________________________________________________|

    12. MIASTENIA GRAVIS
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 51.|  1.| H02A B07 | Prednisonum                                             |
|____|____|__________|_________________________________________________________|
| 52.|  2.| N07A A01 | Neostigmini bromidum                                    |
|____|____|__________|_________________________________________________________|
| 53.|  3.| N07A A02 | Piridostigminum                                         |
|____|____|__________|_________________________________________________________|

    13. SCLEROZA MULTIPLA
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 54.|  1.| H02A B04 | Methylprednisolonum                                     |
|____|____|__________|_________________________________________________________|
| 55.|  2.| H02A B07 | Prednisonum                                             |
|____|____|__________|_________________________________________________________|
| 56.|  3.| L03A B07 | Interferonum Beta 1a*)                                  |
|____|____|__________|_________________________________________________________|
| 57.|  4.| L03A B08 | Interferonum Beta 1b*)                                  |
|____|____|__________|_________________________________________________________|
| 58.|  5.| L03A X13 | Glatiramer acetat*)                                     |
|____|____|__________|_________________________________________________________|
    *) Se prescriu numai pentru pacientii inclusi in subprogramul <<Preventie si diagnostic precoce in bolile neurologice>>.

    14. BOLI PSIHICE (Schizofrenie, tulburari schizotipale si delirante, tulburari afective, psihoze toxice si infectioase, tulburari psihotice acute, dementele degenerative de tip Alzheimer, vasculare si mixte)
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 59.|  1.| N03A G01 | Acidum valproicum si saruri                             |
|____|____|__________|_________________________________________________________|
| 60.|  2.| N04A A01 | Trihexyphenidilum                                       |
|____|____|__________|_________________________________________________________|
| 61.|  3.| N05A D01 | Haloperidolum                                           |
|____|____|__________|_________________________________________________________|
| 62.|  4.| N05A F01 | Flupentixolum                                           |
|____|____|__________|_________________________________________________________|
| 63.|  5.| N05A H02 | Clozapinum                                              |
|____|____|__________|_________________________________________________________|
| 64.|  6.| N05A L05 | Amisulpridum                                            |
|____|____|__________|_________________________________________________________|
| 65.|  7.| N05A N01 | Lithii carbonas                                         |
|____|____|__________|_________________________________________________________|
| 66.|  8.| N06A A04 | Clomipraminum                                           |
|____|____|__________|_________________________________________________________|
| 67.|  9.| N06A A09 | Amitriptylinum                                          |
|____|____|__________|_________________________________________________________|
| 68.| 10.| N06A A12 | Doxepinum                                               |
|____|____|__________|_________________________________________________________|
| 69.| 11.| N06A A21 | Maprotilinum                                            |
|____|____|__________|_________________________________________________________|
| 70.| 12.| N06A X03 | Mianserinum                                             |
|____|____|__________|_________________________________________________________|
| 71.| 13.| N06D A02 | Donepezilum*)                                           |
|____|____|__________|_________________________________________________________|
| 72.| 14.| N06D A03 | Rivastigminum*)                                         |
|____|____|__________|_________________________________________________________|
    *) Vor fi prescrise numai cu avizul comisiei terapeutice de la nivelul spitalului sau al comisiilor de specialitate din centrele universitare.

    15. LUPUS ERITEMATOS SISTEMIC
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 73.|  1.| H02A B07 | Prednisonum                                             |
|____|____|__________|_________________________________________________________|
| 74.|  2.| L04A X01 | Azathioprinum                                           |
|____|____|__________|_________________________________________________________|
| 75.|  3.| P01B A02 | Hydroxicloroquinum                                      |
|____|____|__________|_________________________________________________________|

    16. POLIARTRITA REUMATOIDA
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 76.|  1.| A07E C01 | Sulphasalazinum                                         |
|____|____|__________|_________________________________________________________|
| 77.|  2.| H02A B01 | Bethamethazonum                                         |
|____|____|__________|_________________________________________________________|
| 78.|  3.| H02A B07 | Prednisonum                                             |
|____|____|__________|_________________________________________________________|
| 79.|  4.| L01B A01 | Methotrexatum                                           |
|____|____|__________|_________________________________________________________|
| 80.|  5.| M01A B01 | Indometacinum                                           |
|____|____|__________|_________________________________________________________|
| 81.|  6.| M01A B05 | Diclofenacum                                            |
|____|____|__________|_________________________________________________________|
| 82.|  7.| M01A C01 | Piroxicamum                                             |
|____|____|__________|_________________________________________________________|
| 83.|  8.| M01A E03 | Ketoprofenum                                            |
|____|____|__________|_________________________________________________________|

    17. SPONDILITA ANKILOPOETICA
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 84.|  1.| A07E C01 | Sulphasalazinum                                         |
|____|____|__________|_________________________________________________________|
| 85.|  2.| H02A B01 | Bethamethazonum                                         |
|____|____|__________|_________________________________________________________|
| 86.|  3.| M01A B05 | Diclofenacum                                            |
|____|____|__________|_________________________________________________________|
| 87.|  4.| M01A C01 | Piroxicamum                                             |
|____|____|__________|_________________________________________________________|
| 88.|  5.| M01A X17 | Nimesulidum                                             |
|____|____|__________|_________________________________________________________|

    18. CHISTUL HIDATIC
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 89.|  1.| P02B A01 | Praziquantelum                                          |
|____|____|__________|_________________________________________________________|
| 90.|  2.| P02C A03 | Albendazolum                                            |
|____|____|__________|_________________________________________________________|

    19. MALARIE
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 91.|  1.| P01B A02 | Hydroxicloroquinum                                      |
|____|____|__________|_________________________________________________________|

    20. TUBERCULOZA, MICOBACTERIOZELE ATIPICE SI MUCOVISCIDOZA*)

    *) Pentru mucoviscidoza se indica antibioterapie in functie de susceptibilitatea bacteriana, medicatie mucolitica, bronhodilatatoare si corticoizi.

    Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor sanitare, prin care se deruleaza Programul National de TBC.

    21. TUMORI MALIGNE
    Medicamentele aferente grupei "Tumori maligne" sunt incluse in grupa "Leucemii, limfoame si aplazia medulara".
    Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor sanitare, prin care se deruleaza Programul National de Cancer.

    22. DIABET ZAHARAT SI BOLI DE NUTRITIE
    Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor sanitare, prin care se deruleaza Programul National de Diabet si Boli de Nutritie.

    23. BOLI ENDOCRINE (Gusa endemica, boala Addison, diabetul insipid, mixedemul adultului)
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 92.|  1.| H02A A02 | Fludrocortizonum                                        |
|____|____|__________|_________________________________________________________|
| 93.|  2.| H02A B09 | Hydrocortizonum                                         |
|____|____|__________|_________________________________________________________|
| 94.|  3.| H02A D07 | Prednisonum                                             |
|____|____|__________|_________________________________________________________|
| 95.|  4.| H03A A01 | Levothyroxinum                                          |
|____|____|__________|_________________________________________________________|
| 96.|  5.| H01B A02 | Desmopressinum                                          |
|____|____|__________|_________________________________________________________|
| 97.|  6.| H03C A   | Iodidum                                                 |
|____|____|__________|_________________________________________________________|
| 98.|  7.| H03C A01 | Kalii iodidum                                           |
|____|____|__________|_________________________________________________________|

    24. BOALA WILLSON
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 99.|  1.| M01C C01 | Penicillaminum                                          |
|____|____|__________|_________________________________________________________|

    25. STARI POST TRANSPLANT
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
|100.|  1.| A05A A02 | Acidum ursodeoxycholicum                                |
|____|____|__________|_________________________________________________________|
|101.|  2.| H02A B04 | Methylprednisolonum                                     |
|____|____|__________|_________________________________________________________|
|102.|  3.| H02A B07 | Prednisonum                                             |
|____|____|__________|_________________________________________________________|
|103.|  4.| J01E E01 | Sulphamethoxazolum + Trimethoprimum                     |
|____|____|__________|_________________________________________________________|
|104.|  5.| J02A C01 | Fluconazolum                                            |
|____|____|__________|_________________________________________________________|
|105.|  6.| J05A F05 | Lamivudinum                                             |
|____|____|__________|_________________________________________________________|
|106.|  7.| L04A A01 | Ciclosporinum                                           |
|____|____|__________|_________________________________________________________|
|107.|  8.| L04A X01 | Azathioprinum                                           |
|____|____|__________|_________________________________________________________|

    Se vor prescrie la recomandarea Centrului care a efectuat transplantul pentru pacientii inclusi in subprogramul <<Transplant de organe si tesuturi>>.

    26. INSUFICIENTA RENALA CRONICA

    27. GLAUCOM
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
|108.|  1.| S01E B01 | Pilocarpinum                                            |
|____|____|__________|_________________________________________________________|
|109.|  2.| S01E C01 | Acetazolamidum                                          |
|____|____|__________|_________________________________________________________|
|110.|  3.| S01E D01 | Timololum                                               |
|____|____|__________|_________________________________________________________|
|111.|  4.| S01E D05 | Carteololum                                             |
|____|____|__________|_________________________________________________________|
|112.|  5.| S01E X03 | Latanoprostum                                           |
|____|____|__________|_________________________________________________________|

    28. BOLI VENERICE [Sifilis, gonoree, infectia cu Clamidia*)]
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
|113.|  1.| J01A A02 | Doxycyclinum                                            |
|____|____|__________|_________________________________________________________|
|114.|  2.| J01A A07 | Tetracyclinum                                           |
|____|____|__________|_________________________________________________________|
|115.|  3.| J01C E01 | Benzylpenicillinum                                      |
|____|____|__________|_________________________________________________________|
|116.|  4.| J01C E08 | Benzathini benzylpenicillinum                           |
|____|____|__________|_________________________________________________________|
|117.|  5.| J01C E09 | Benzylpenicillinum procainicum                          |
|____|____|__________|_________________________________________________________|
|118.|  6.| J01F A01 | Erythromicinum                                          |
|____|____|__________|_________________________________________________________|
|119.|  7.| J01F A07 | Josamycinum                                             |
|____|____|__________|_________________________________________________________|
|120.|  8.| J01M A01 | Ofloxacinum                                             |
|____|____|__________|_________________________________________________________|
    *) Confirmata de laborator

    29. PEMFIGUS
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
|121.|  1.| H01A A02 | Tetracosactidum                                         |
|____|____|__________|_________________________________________________________|
|122.|  2.| H02A B02 | Dexamethazonum                                          |
|____|____|__________|_________________________________________________________|
|123.|  3.| H02A B04 | Methylprednisolonum                                     |
|____|____|__________|_________________________________________________________|
|124.|  4.| H02A B06 | Prednisolonum                                           |
|____|____|__________|_________________________________________________________|
|125.|  5.| H02A B07 | Prednisonum                                             |
|____|____|__________|_________________________________________________________|
|126.|  6.| H02A B08 | Triamcinolonum                                          |
|____|____|__________|_________________________________________________________|
|127.|  7.| H02A B09 | Hydrocortizonum                                         |
|____|____|__________|_________________________________________________________|

    30. PELAGRA
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
|128.|  1.| A11H A01 | Acidum nicotinicum                                      |
|____|____|__________|_________________________________________________________|

    31. BOALA GAUCHER
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
|129.|  1.| A16A B02 | Imiglucerasum*)                                         |
|____|____|__________|_________________________________________________________|
    *) Dupa precizarea diagnosticului de catre Centrul de Boli Genetice - Cluj-Napoca va putea fi prescris de catre sefii clinicilor universitare de profil (Endocrinometabolice sau gastroenterologice), sau de catre sefii sectiilor respective de la nivelul spitalului judetean.

    NOTA:
    Pentru medicamentele din aceasta sectiune tratamentul se initiaza de medicul de specialitate, luandu-se in considerare mentiunile cu caracter special, notate cu asterisc.

    Sectiunea B - Medicamente cu restrictie la prescriere - optiunea 2, avizarea prescriptiei medicale

    1. INSUFICIENTA CARDIACA CRONICA

    2. BOLNAVI CU PROTEZE VALVULARE SI VASCULARE
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
|  1.|  1.| B01A C04 | Clopidogrelum*)                                         |
|____|____|__________|_________________________________________________________|
|  2.|  2.| B01A C05 | Ticlopidinum                                            |
|____|____|__________|_________________________________________________________|
    *) Prescrierea va fi avizata de seful de sectie si/sau clinica, dupa caz, si aprobata de directorul de spital.

    3. ACCIDENT VASCULAR CEREBRAL POSTACUT (inclusiv atacul vascular cerebral tranzitoriu)
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
|  3.|  1.| B01A B04 | Dalteparinum                                            |
|____|____|__________|_________________________________________________________|
|  4.|  2.| B01A B05 | Enoxaparinum                                            |
|____|____|__________|_________________________________________________________|
|  5.|  3.| B01A B06 | Nadroparinum                                            |
|____|____|__________|_________________________________________________________|
|  6.|  4.| B01A B08 | Reviparinum                                             |
|____|____|__________|_________________________________________________________|
|  7.|  5.| B01A B10 | Tinzaparinum                                            |
|____|____|__________|_________________________________________________________|
|  8.|  6.| B01A C04 | Clopidogrelum*)                                         |
|____|____|__________|_________________________________________________________|
    *) Prescrierea va fi avizata de seful de sectie si/sau clinica, dupa caz, si aprobata de directorul de spital.

    4. HEPATITA VIRALA ACUTA (cu HAV, HBV, HCV sau HGV), hepatitele cronice de etiologie virala (cu markeri de replicare virala pozitivi).
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
|  9.|  1.| J05A B04 | Ribavirinum*)                                           |
|____|____|__________|_________________________________________________________|
| 10.|  2.| J05A F05 | Lamivudinum*)                                           |
|____|____|__________|_________________________________________________________|
| 11.|  3.| L03A B04 | Interferonum Alfa 2a*)                                  |
|____|____|__________|_________________________________________________________|
| 12.|  4.| L03A B05 | Interferonum Alfa 2b*)                                  |
|____|____|__________|_________________________________________________________|
| 13.|  5.| L03A B10/| Peginterferonum Alfa*)                                  |
|    |    | L03A B11 |                                                         |
|____|____|__________|_________________________________________________________|
    *) Se vor prescrie cu avizul Comisiilor Institutelor de specialitate sau din Centrele Universitare si vor fi aprobate de catre Comisia Centrala de la nivelul Casei Nationale de Asigurari de Sanatate.

    5. CIROZA HEPATICA
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 14.|  1.| A07A A11 | Rifaximinum                                             |
|____|____|__________|_________________________________________________________|
| 15.|  2.| C03A A03 | Hydrochlorothiazidum                                    |
|____|____|__________|_________________________________________________________|
| 16.|  3.| H02A B04 | Methylprednisolonum                                     |
|____|____|__________|_________________________________________________________|
| 17.|  4.| J01M A02 | Ciprofloxacinum                                         |
|____|____|__________|_________________________________________________________|

    6. HIV/SIDA
    Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor sanitare, prin care se deruleaza Programul National HIV/SIDA.

    7. TALASEMIE

    8. LEUCEMII, LIMFOAME SI APLAZIE MEDULARA
       TUMORI MALIGNE
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 18.|  1.| A04A A02 | Granisetronum                                           |
|____|____|__________|_________________________________________________________|
| 19.|  2.| B03X A01 | Epoetinum                                               |
|____|____|__________|_________________________________________________________|
| 20.|  3.| H01B A02 | Desmopressinum                                          |
|____|____|__________|_________________________________________________________|
| 21.|  4.| H03A A01 | Levothyroxinum                                          |
|____|____|__________|_________________________________________________________|
| 22.|  5.| L01D B02 | Daunorubicinum                                          |
|____|____|__________|_________________________________________________________|
| 23.|  6.| L02B G02 | Formestanum                                             |
|____|____|__________|_________________________________________________________|
| 24.|  7.| L04A A01 | Ciclosporinum                                           |
|____|____|__________|_________________________________________________________|
| 25.|  8.| N02A D01 | Pentazocinum                                            |
|____|____|__________|_________________________________________________________|
| 26.|  9.| N03A F01 | Carbamazepinum                                          |
|____|____|__________|_________________________________________________________|

    NOTA:
    Medicamentele (D.C.I.) aferente grupei "Leucemii, limfoame si aplazie medulara" sunt listate impreuna cu cele corespunzatoare grupei "Tumori maligne" datorita faptului ca un numar mare de produse sunt comune celor doua grupe.
    Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor sanitare, prin care se deruleaza Programul National de Cancer.

    9. EPILEPSIE
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 27.|  1.| N03A X12 | Gabapentinum                                            |
|____|____|__________|_________________________________________________________|

    10. BOALA PARKINSON
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 28.|  1.| N04B B01 | Amantadinum                                             |
|____|____|__________|_________________________________________________________|
| 29.|  2.| N04B C01 | Bromocriptinum                                          |
|____|____|__________|_________________________________________________________|
| 30.|  3.| N04B X02 | Entacaponum*)                                           |
|____|____|__________|_________________________________________________________|
| 31.|  4.| N05A H02 | Clozapinum*)                                           |
|____|____|__________|_________________________________________________________|
    *) Se vor prescrie cu avizul Comisiilor Institutelor de specialitate sau din Centrele Universitare.
    *) Parkinsonian cu tulburari psihotice

    11. MIOPATII (MIOPATIILE INFLAMATORII)
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 32.|  1.| H02A B02 | Dexametazonum                                           |
|____|____|__________|_________________________________________________________|
| 33.|  2.| H02A B04 | Methilprednisolonum                                     |
|____|____|__________|_________________________________________________________|
| 34.|  3.| L01B A01 | Methotrexatum                                           |
|____|____|__________|_________________________________________________________|
| 35.|  4.| L04A X01 | Azathioprinum                                           |
|____|____|__________|_________________________________________________________|
| 36.|  5.| P01B A02 | Hydroxicloroquinum                                      |
|____|____|__________|_________________________________________________________|

    12. MIASTENIA GRAVIS
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 37.|  1.| H01A A02 | Tetracosactidum                                         |
|____|____|__________|_________________________________________________________|
| 38.|  2.| H02A B02 | Dexamethasonum                                          |
|____|____|__________|_________________________________________________________|
| 39.|  3.| H02A B04 | Methylprednisolonum                                     |
|____|____|__________|_________________________________________________________|
| 40.|  4.| L04A X01 | Azathioprinum                                           |
|____|____|__________|_________________________________________________________|

    13. SCLEROZA MULTIPLA
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 41.|  1.| L01B A01 | Methotrexatum                                           |
|____|____|__________|_________________________________________________________|
| 42.|  2.| L04A X01 | Azathioprinum                                           |
|____|____|__________|_________________________________________________________|

    14. BOLI PSIHICE (Schizofrenie, tulburari schizotipale si delirante, tulburari afective, psihoze toxice si infectioase, tulburari psihotice acute, dementele degenerative de tip Alzheimer, vasculare si mixte)
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 43.|  1.| N04A A02 | Biperidenum                                             |
|____|____|__________|_________________________________________________________|
| 44.|  2.| N04B D01 | Selegilinum*)                                           |
|____|____|__________|_________________________________________________________|
| 45.|  3.| N05A X08 | Risperidonum*)                                          |
|____|____|__________|_________________________________________________________|
| 46.|  4.| N05A F05 | Zuclopentixolum*)                                       |
|____|____|__________|_________________________________________________________|
| 47.|  5.| N05A H03 | Olanzapinum*)                                           |
|____|____|__________|_________________________________________________________|
| 48.|  6.| N05A H04 | Quetiapinum*)                                           |
|____|____|__________|_________________________________________________________|
    *) Prescrierea va fi avizata de seful de sectie si/sau clinica, dupa caz, si aprobata de directorul de spital.

    15. LUPUS ERITEMATOS SISTEMIC
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 49.|  1.| H02A B04 | Methylprednisolonum                                     |
|____|____|__________|_________________________________________________________|
| 50.|  2.| L01A A01 | Cyclophosphamidum                                       |
|____|____|__________|_________________________________________________________|
| 51.|  3.| L01B A01 | Methotrexatum*)                                         |
|____|____|__________|_________________________________________________________|
| 52.|  4.| L04A A01 | Ciclosporinum                                           |
|____|____|__________|_________________________________________________________|
| 53.|  5.| L04A A06 | Mycophenolatum                                          |
|____|____|__________|_________________________________________________________|
    *) Prescrierea va fi avizata de seful de sectie si/sau clinica, dupa caz, si aprobata de directorul de spital.

    16. POLIARTRITA REUMATOIDA
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 54.|  1.| H02A B04 | Methylprednisolonum                                     |
|____|____|__________|_________________________________________________________|
| 55.|  2.| L04A A01 | Ciclosporinum                                           |
|____|____|__________|_________________________________________________________|
| 56.|  3.| L04A A12 | Infliximabum*)                                         |
|____|____|__________|_________________________________________________________|
| 57.|  4.| L04A A13 | Leflunomidum*)                                          |
|____|____|__________|_________________________________________________________|
| 58.|  5.| L04A X01 | Azathioprinum                                           |
|____|____|__________|_________________________________________________________|
| 59.|  6.| M01BXN2  | Combinatii: Diclofenacum + Misoprostolum*)            |
|____|____|__________|_________________________________________________________|
| 60.|  7.| M01C B01 | Natrii aurothiomalas                                    |
|____|____|__________|_________________________________________________________|
| 61.|  8.| P01B A02 | Hydroxichloroquinum                                     |
|____|____|__________|_________________________________________________________|
    *) Leflunomidum: contraindicatie sau precautie la cei cu leziuni hepatice preexistente (EMEA); se administreaza la pacientii cu poliartrita reumatoida care nu raspund adecvat la metotrexat sau sulfasalazina;
    *) Infliximabum: la pacientii cu poliartrita reumatoida severa care nu raspund adecvat la metotrexat se asociaza infliximabum, cu aprobarea comisiei centrale de la nivelul Casei Nationale de Asigurari de Sanatate;
    *) Se prescrie la pacientii care nu tolereaza celelalte antiinflamatoare din lista.

    17. SPONDILITA ANKILOPOETICA
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 62.|  1.| L01B A01 | Methotrexatum                                           |
|____|____|__________|_________________________________________________________|
| 63.|  2.| M01A C06 | Meloxicamum                                             |
|____|____|__________|_________________________________________________________|

    18. CHISTUL HIDATIC

    19. MALARIE

    20. TUBERCULOZA, MICOBACTERIOZELE ATIPICE SI MUCOVISCIDOZA*)

    *) Pentru mucoviscidoza se indica antibioterapie in functie de susceptibilitatea bacteriana, medicatie mucolitica, bronhodilatatoare si corticoizi.

    Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor sanitare, prin care se deruleaza Programul National de TBC

    21. TUMORI MALIGNE
    Medicamentele aferente grupei "Tumori maligne" sunt incluse in grupa "Leucemii, limfoame si aplazia medulara"
    Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor sanitare, prin care se deruleaza Programul National de Cancer.

    22. DIABET ZAHARAT SI BOLI DE NUTRITIE
    Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor sanitare, prin care se deruleaza Programul National de Diabet si Boli de Nutritie.

    23. BOLI ENDOCRINE (Gusa endemica, boala Addison, diabetul insipid, mixedemul adultului)

    24. BOALA WILLSON

    25. STARI POST TRANSPLANT
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 64.|  1.| J05A B01 | Aciclovirum                                             |
|____|____|__________|_________________________________________________________|
| 65.|  2.| J05A B06 | Ganciclovirum                                           |
|____|____|__________|_________________________________________________________|
| 66.|  3.| L04A A05 | Tacrolimus                                              |
|____|____|__________|_________________________________________________________|
| 67.|  4.| L04A A06 | Mycophenolatum                                          |
|____|____|__________|_________________________________________________________|
| 68.|  5.| L04A A10 | Sirolimus                                               |
|____|____|__________|_________________________________________________________|

    Se vor prescrie cu avizul centrului care a efectuat transplantul, pentru pacientii inclusi in subprogramul <<Transplant de organe si tesuturi>>.

    26. INSUFICIENTA RENALA CRONICA
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 69.|  1.| A11C C03 | Alfacalcidolum                                          |
|____|____|__________|_________________________________________________________|
| 70.|  2.| B03X A01 | Epoetinum                                               |
|____|____|__________|_________________________________________________________|

    Se prescriu numai pentru pacientii inclusi in subprogramul <<Preventie in patologia nefrologica si dializa>>.

    27. GLAUCOM
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 71.|  1.| S01E C03 | Dorzolamidum                                            |
|____|____|__________|_________________________________________________________|
| 72.|  2.| S01E C04 | Brinzolamidum                                           |
|____|____|__________|_________________________________________________________|
| 73.|  3.| S01E D02 | Betaxololum                                             |
|____|____|__________|_________________________________________________________|

    28. BOLI VENERICE [Sifilis, gonoree, infectia cu Clamidia*)]
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 74.|  1.| J01D A06 | Cefuroximum                                             |
|____|____|__________|_________________________________________________________|
| 75.|  2.| J01D A13 | Ceftriaxonum                                            |
|____|____|__________|_________________________________________________________|
| 76.|  3.| J01D A39 | Ceftibutenum                                            |
|____|____|__________|_________________________________________________________|
| 77.|  4.| J01E E01 | Sulfamethoxazolum + Trimethoprimum                      |
|____|____|__________|_________________________________________________________|
| 78.|  5.| J01F A10 | Azithromycinum                                          |
|____|____|__________|_________________________________________________________|
| 79.|  6.| J01M A02 | Ciprofloxacinum                                         |
|____|____|__________|_________________________________________________________|
| 80.|  7.| J01M A06 | Norfloxacinum                                           |
|____|____|__________|_________________________________________________________|
    *) Confirmata de laborator

    29. PEMFIGUS
 ______________________________________________________________________________
|Nr. |Nr. | Grupa    |                          D.C.I.                         |
|crt.|crt.| ATC      |                                                         |
|____|____|__________|_________________________________________________________|
| 81.|  1.| J04B A02 | Dapsonum                                                |
|____|____|__________|_________________________________________________________|
| 82.|  2.| L01A A01 | Cyclophosphamidum                                       |
|____|____|__________|_________________________________________________________|
| 83.|  3.| L01B A01 | Methotrexatum                                           |
|____|____|__________|_________________________________________________________|
| 84.|  4.| L04A A01 | Ciclosporinum*)                                         |
|____|____|__________|_________________________________________________________|
| 85.|  5.| L04A X01 | Azathioprinum                                           |
|____|____|__________|_________________________________________________________|
    *) Prescrierea va fi avizata de seful de sectie si/sau clinica, dupa caz, si aprobata de directorul de spital.

    30. PELAGRA

    31. BOALA GAUCHER

    NOTA:
    Medicamentele cuprinse in aceasta sectiune sunt recomandate si prescrise numai in una din urmatoarele situatii: cand prin folosirea medicamentelor din Sectiunea A nu se obtine un raspuns terapeutic adecvat, reactiile adverse sunt majore, exista contraindicatii datorate unei boli asociate sau cand numai medicamentele din aceasta Sectiune B reprezinta solutia terapeutica exclusiva.
    Tratamentul cu aceste medicamente se initiaza de medicul de specialitate, luandu-se in considerare mentiunile cu caracter special notate cu asterisc (*).
    Prescrierea medicamentelor din aceasta sectiune se va aviza cel putin de catre comisia terapeutica a spitalului din aceasta sectiune.

    ANEXA 2

    LISTA DENUMIRILOR COMUNE INTERNATIONALE ALE PRODUSELOR MEDICAMENTOASE DE CARE BENEFICIAZA ASIGURATII, IN AMBULATORIU CU CONTRIBUTIE PERSONALA

    Sectiunea A - Medicamente de baza, optiune terapeutica 1

    Nivelul de compensare pentru medicamentele corespunzatoare acestor DCI este de 65% (*)

    1. A02B BISMUTHI SUBCITRAS
    2. A02B FAMOTIDINUM
    3. A02B LANSOPRAZOLUM
    4. A02B OMEPRAZOLUM
    5. A02B RANITIDINUM
    6. A03A MEBEVERINUM
    7. A03B BUTYLSCOPOLAMMONII BROMIDUM
    8. A03F METOCLOPRAMIDUM
    9. A04A PROCHLORPERAZINUM
    10. A07A NYSTATINUM
    11. A07D LOPERAMIDUM
    12. A07E MESALAZINUM - numai in caz de intoleranta la SULFASALAZINUM*)
    13. A07E SULFASALAZINUM*)
    14. A11C ALFACALCIDOLUM

    15. B01A ACENOCOUMAROLUM*)
    16. B02B PHYTOMENADIONUM
    17. B03A FERROSII FUMARAS
    18. B03A FERROSII GLUTAMAS
    19. B03A FERROSII SULFAS

    20. C01A DIGOXINUM
    21. C01B AMIODARONUM*)
    22. C01B CHINIDINI SULFAS*)

    23. C01B MEXILETINUM*)
    24. C01B PROPAFENONUM*)
    25. C01D ISOSORBIDI DINITRAS
    26. C01D ISOSORBIDI MONONITRAS
    27. C01D NITROGLYCERINUM
    28. C01E TRIMETAZIDINUM
    29. C02A CLONIDINUM
    30. C02C PRAZOSINUM
    31. C02A DIHYDRALAZINUM - in combinatii
    32. C03A HIDROCHLOROTHIAZIDUM
    33. C03B INADAPAMIDUM
    34. C03C FUROSEMIDUM
    35. C03D SPIRONOLACTONUM
    36. C07A ATENOLOLUM
    37. C07A BETAXOLOLUM
    38. C07A BISOPROLOLUM
    39. C07A CARVEDILOLUM
    40. C07A METOPROLOLUM
    41. C07A NEBIVOLOLUM
    42. C07A PROPRANOLOLUM
    43. C07A SOTALOLUM - numai ca antiaritmic*)
    44. C08C NIFEDIPINUM cu eliberare prelungita
    45. C08D DILTIAZEMUM*)
    46. C08D VERAPAMILUM*)
    47. C09A CAPTOPRILUM
    48. C09A ENALAPRILUM
    49. C09A FOSINOPRILUM*)
    50. C09A LISINOPRILUM*)
    51. C09A PERINDOPRILUM*)
    52. C09A QUINAPRILUM*)
    53. C09A RAMIPRILUM*)
    54. C09A BENAZEPRILUM*)
    55. C09A TRANDOLAPRILUM*)
    56. C10A BEZAFIBRATUM
    57. C10A GEMFIBROZILUM
    58. C10A FENOFIBRATUM
    59. C10A SIMVASTATINUM*)

    60. D01A BIFONAZOLUM
    61. D01A MICONAZOLUM
    62. D01B GRISEOFULVINUM*)
    63. D06B PODOPHYLLOTOXINUM*)
    64. D07A CLOBETASOLUM
    65. D07A FLUMETASONUM
    66. D07A HYDROCORTIZONUM
    67. D07A TRIAMCINOLONUM ACETONID

    68. G02A METHYLERGOMETRINUM*)
    69. G02C BROMOCRIPTINUM*)
    70. G03A MEDROXYPROGESTERONUM*)
    71. G03B TESTOSTERONUM*)
    72. G03C ESTRADIOLUM*)
    73. G03C ESTRIOLUM*)
    74. G03D LYNESTRENOLUM*)
    75. G03D PROGESTERONUM*)
    76. G03F (G03C) ESTROGENI - simpli si combinatii*)
    77. G03G CLOMIFENUM*)
    78. G04C DOXAZOSINUM*)
    79. G04C TERAZOSINUM*)
    80. H02A DEXAMETHASONUM
    81. H02A METHYLPREDNISOLONUM*)
    82. H02A PREDNISOLONUM
    83. H02A PREDNISONUM
    84. H03B CARBIMAZOLUM*)
    85. H03B THIAMAZOLUM*)

    86. J01A DOXYCYCLINUM
    87. J01A TETRACYCLINUM
    88. J01C AMOXICILLINUM
    89. J01C AMPICILLINUM
    90. J01C BENZATHINI BENZYLPENICILLINUM
    91. J01C BENZYLPENICILLINUM
    92. J01C OXACILLINUM
    93. J01C PHENOXYMETHYLPENICILLINUM
    94. J01D CEFACLORUM
    95. J01D CEFALEXINUM (ORAL)
    96. J01D CEFUROXIMUM (ORAL)
    97. J01E SULFAMETHOXAZOLUM + TRIMETHOPRIMUM
    98. J01F ERYTROMYCINUM
    99. J01G GENTAMICINUM
    100. J01M CIPROFLOXACINUM
    101. J01M NORFLOXACINUM
    102. J01X METRONIDAZOLUM
    103. J01X TINIDAZOLUM
    104. J02A FLUCONAZOLUM (ORAL)
    105. J02A KETOCONAZOLUM
    106. J05A ACICLOVIRUM
    107. J01M OFLOXACINUM
    108. M01A DICLOFENACUM
    109. M01A INDOMETACINUM
    110. M01A KETOPROFENUM
    111. M01A NIMESULIDUM

    112. M01A PIROXICAMUM
    113. M01A TENOXICAMUM
    114. M03B TETRAZEPAMUM
    115. M04A ALLOPURINOLUM*)
    116. M04A COLCHICINUM*)

    117. N02A TRAMADOLUM
    118. N03A CARBAMAZEPINUM
    119. N05A CHLORPROMAZINUM
    120. N05A THIORIDAZINUM
    121. N05B ALPRAZOLAMUM
    122. N05B BROMAZEPAMUM
    123. N05B DIAZEPAMUM
    124. N05B HYDROXYZINUM
    125. N05B MEDAZEPAMUM
    126. N05B OXAZEPAMUM
    127. N05C NITRAZEPAMUM
    128. N07C BETAHISTINUM
    129. N07X ACIDUM ALFA-LIPOICUM

    130. P02B PRAZIQUANTELUM
    131. P02C MEBENDAZOLUM
    132. P02C ALBENDAZOLUM
    133. P02C LEVAMISOLUM

    134. R03A SALBUTAMOLUM
    135. R03B ACIDUM CROMOGLICICUM
    136. R03B BECLOMETHASONUM
    137. R03B BUDESONIDUM
    138. R03D AMINOPHYLLINUM
    139. R03D THEOPHILLINUM
    140. R05D CODEINUM
    141. R06A CHLORPHENIRAMINUM (CHLORPHENA)
    142. R06A KETOTIFENUM
    143. R06A LORATADINUM
    144. R06A PROMETHAZINUM

    145. S01A CIPROFLOXACINUM
    146. S01C TOBRAMICINUM + DEXAMETAZONUM
    147. S01G ACIDUM CROMOGLICICUM

    NOTA:
    Tratamentul cu medicamentele notate cu asterisc (*) se initiaza de medicul de specialitate in limita competentei si poate fi prescris in continuare de medicul de familie pe baza scrisorii medicale emisa de medicul de specialitate.

    Sectiunea B - Medicamente cu restrictie la prescriere optiune terapeutica 2

    Nivelul de compensare pentru medicamentele corespunzatoare acestor DCI este de 50% (*)

    1. A02B NIZATIDINUM
    2. A02B PANTOPRAZOLUM
    3. A02B SUCRALFATUM
    4. A03A OTILONIUM BROMIDUM
    5. A03A TRIMEBUTINUM
    6. A03F DOMPERIDONUM
    7. A11C COLECALCIFEROLUM

    8. B01A CLOPIDOGRELUM - pentru pacientii cu intoleranta la aspirina
    9. B01A SULODEXIDUM
    10. B01A TICLOPIDINUM - pentru pacientii cu intoleranta la aspirina
    11. B03A COMPLEX DE HIDROXID DE FIER (III)

    12. C02A METHYLDOPUM
    13. C02A MOXONIDINUM
    14. C04A CODERGOCRINUM
    15. C04A NICERGOLINUM
    16. C04A PENTOXIFYLLINUM
    17. C04A VINCAMINUM
    18. C05C DIOSMINUM - simplu si in combinatii
    19. C08C AMLODIPINUM
    20. C08C FELODIPINUM
    21. C08C LERCANIDIPINUM
    22. C09C CANDESARTANUM
    23. C09C IRBESARTANUM
    24. C09C LOZARTANUM
    25. C09C TELMISARTANUM
    26. C09C VALSARTANUM
    27. C10A ATORVASTATINUM
    28. C10A CIPROFIBRATUM
    29. C10A FLUVASTATINUM
    30. C10A PRAVASTATINUM

    31. D01A NAFTIFINUM
    32. D01A NATAMYCINUM
    33. D01B TERBINAFINUM
    34. D05A CALCIPOTRIOLUM
    35. D06A MUPIROCINUM
    36. D06B SULFADIAZINUM
    37. D07A METHYLPREDNISOLONUM
    38. D07X MOMETASONUM
    39. D10A ACIDUM AZELAICUM
    40. D10B ISOTRETINOINUM

    41. G01A FENTICONAZOLUM
    42. G03C HEXESTROLUM
    43. G03C PROMESTRIENUM
    44. G03D DYDROGESTERONUM
    45. G03X RALOXIFENUM
    46. G04B EMEPRONII BROMIDUM
    47. G04B OXYBUTYNINUM
    48. G04C ALFUZOSINUM
    49. G04C FINASTERIDUM
    50. G04C TAMSULOSINUM

    51. H01A TETRACOSACTIDUM
    52. H02A BETAMETHASONUM
    53. H02A FLUDROCORTISONUM
    54. H02A HYDROCORTISONUM
    55. H05B CALCITONINUM

    56. J01C AMOXICILLINUM + ACIDUM CLAVULANICUM
    57. J01C SULTAMICILLINUM
    58. J01D CEFTIBUTENUM (ORAL)
    59. J01F AZITHROMICINUM
    60. J01F CLARITHROMYCINUM
    61. J01F CLINDAMYCINUM
    62. J02A ITRACONAZOLUM
    63. M01A CELECOXIBUM
    64. M01A MELOXICAMUM
    65. M01A ROFECOXIBUM
    66. M03B BACLOFENUM
    67. M05B ACIDUM ALENDRONICUM
    68. M05B ACIDUM PAMIDRONICUM

    69. N02C SUMATRIPTANUM
    70. N02C RIZATRIPTANUM
    71. N05A SULPIRIDUM
    72. N05A TIAPRIDUM
    73. N05C ZOLPIDEMUM
    74. N05C ZOPICLONUM
    75. N06A FLUVOXAMINUM
    76. N06A MILNACIPRANUM
    77. N06A MIRTAZAPINUM
    78. N06A PAROXETINUM
    79. N06A REBOXETINUM
    80. N06A SERTRALINUM
    81. N06A TIANEPTINUM
    82. N06A VENLAFAXINUM
    83. N06A FLUOXETINUM
    84. N06B PRAMIRACETAMUM
    85. N06B VINPOCETINUM
    86. N06D GINKGO BILOBA (extract standardizat conform Pharmacopeei]
    87. N07X HIDROLIZAT DE PROTEINA DIN CREIER DE PORCINA

    88. P01B HYDROXYCHLOROQUINUM

    89. R03A FENOTEROLUM
    90. R03A SALMETEROLUM
    91. R03A SALMETEROLUM + FLUTICASONUM
    92. R03A TERBUTALINUM
    93. R03B FLUTICASONUM
    94. R03B IPRATROPII BROMIDUM
    95. R03D MONTELUKAST
    96. R05D DEXTROMETHORPHANUM
    97. R05D LEVODROPROPIZINUM
    98. R06A FEXOFENADINUM
    99. R06A DESLORATADINUM
    100. R06A THIETHYLPERAZINUM
    101. S01G EMEDASTINUM

    NOTA:
    Medicamentele cuprinse in aceasta sectiune sunt recomandate si prescrise numai in una din urmatoarele situatii: cand prin folosirea medicamentelor din Sectiunea A nu se obtine un raspuns terapeutic adecvat, reactiile adverse sunt majore, exista contraindicatii datorate unei boli asociate sau cand numai medicamentele din aceasta Sectiune B reprezinta solutia terapeutica exclusiva.
    Medicamentele vor fi prescrise de medicul de specialitate; prescrierea poate fi continuata conform schemei terapeutice de tratament prescrisa de medicul de specialitate si de catre medicul de familie.
    (*) Cota procentuala de 65%, respectiv 50%, se aplica la pretul cel mai mic corespunzator unitatii terapeutice aferente aceleiasi forme farmaceutice, din cadrul aceleiasi denumiri comune internationale si pentru fiecare concentratie. Valoarea astfel rezultata reprezinta pretul de referinta.